A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
This study has suspended participant recruitment.
(This study is suspended for further analysis of the pre-clinical toxicology data)
Sponsor:
Astellas Pharma Inc
Information provided by (Responsible Party):
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT01442337
First received: September 16, 2011
Last updated: April 3, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |